Ethyl 2-((2,4-difluorophenyl)amino)-2-oxoacetate, 95%, 500mg

(Pentylsulfanyl)benzene, 98.0%, 25g

2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

Boc-L-Homoserine lactone, 95.0%, 5g

3-Phenylumbelliferone>98.0%(GC)5g

2-[(2,5-dioxopyrrolidin-3-yl)thio]benzoic acid, 95.0%, 1g

N-Cyclopropyl-1-methylpiperidin-4-amine, 95.0%, 1g

4-Bromo-2-chlorobenzyl bromide, 95.0%, 10g

2-Chloro-4-methylbenzothiazole, 95.0%, 1g

(5Z)-5-[[5-(4-Fluoro-2-hydroxyphenyl)-2-furanyl]methylene]-2,4-thiazolidinedione, 98%, 1mg

(2R,4R)-1-(tert-Butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid, 95.0%, 25g

Set misurini ROTILABO®, 1 set

Colonna capillare per GC ROTI®Cap-1701, 25 m, 0,32 mm, 0,35 µm, 1 Pezzo(i)